CommentaryA pill a day, or two, for hepatitis B?
References (17)
- et al.
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis
Lancet
(1996) - et al.
Treatment of fibrosing cholestatic hepatitis with lamivudine
Gastroenterology
(1998) - et al.
Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine
Hepatology
(1996) In vitro evaluation of combination therapies against hepatitis B virus replication
Antiviral Res
(1996)- et al.
A preliminary trial of lamivudine for chronic hepatitis B infection
N Engl J Med
(1995) - et al.
A one-year trial of lamivudine for chronic hepatitis B
N Engl J Med
(1998) - et al.
Efficacy of lamivudine in patients with hepatitis B e antigne-negative/hepatitis B virus DNA-posiotive (precore mutant) chronic hepatitis B
Hepatology
(1999) - et al.
Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation
Transplantation
(1998)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1999 Elsevier Ltd. All rights reserved.